Cover Image

Results of mutation status gene HER-2/NEU in patients with breast cancer in Ukraine

Saved in:

Bibliographic Details
Date:	2017
Main Authors:	B. T. Klimuk, O. M. Duhan, A. V. Stefanovych, S. V. Klymenko
Format:	Article
Language:	English
Published:	2017
Series:	Factors in experimental evolution of organisms
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0000800082
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Impact of ASCO/CAP 2007, 2013 and 2018 recommendations on Her-2/neu gene amplification status testing in patients with breast cancer
by: B. T. Klimuk, et al.
Published: (2019)

Surgery features in the treatment of patients with HER2-neu positive breast cancer
by: I. Y. Halaichuk
Published: (2020)

Association of genetic polymorphism with the mutation status of the BRCA1/2 genes in spontanous breast cancer
by: Polinyk, S.I., et al.
Published: (2017)

Orally given chemo-endocrine therapy for patients with luminal Her-2/neu negative metastasing breast cancer
by: Yu. O. Tymovska, et al.
Published: (2016)

Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer
by: Shapochka, D.O., et al.
Published: (2012)

Study of trace elements status of breast cancer patients
by: M. N. Tillashaykhov, et al.
Published: (2017)

Study of trace elements status of breast cancer patients
by: Tillashaykhov, M.N, et al.
Published: (2017)

Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
by: Zakhartseva, L.M., et al.
Published: (2009)

Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas
by: Buchynska, L.G., et al.
Published: (2023)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)

Screening for mutations in BRCA1 and BRCA2 genes and related perspectives for the healthcare system
by: Ya. O. Tabaliuk, et al.
Published: (2020)

Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: J. Zekri, et al.
Published: (2015)

Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: Zekri, J., et al.
Published: (2015)

Оценка мутационного статуса гена Her2/neu в клетках рака молочной железы
by: Клименко, С.В., et al.
Published: (2007)

Особливості експресії білків HER-2/neu та VEGF у граничних пухлинах яєчника
by: Клименко, Е.С., et al.
Published: (2014)

Експресія Her2/neu при недрібноклітинному раку легені та її прогностичне значення
by: Суховерша, О.А., et al.
Published: (2007)

FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
by: Arabpour, F., et al.
Published: (2018)

Mutation 6174delT in the BRCA2 gene in men with prostate cancer in Ukraine
by: Ye. V. Horodetska, et al.
Published: (2018)

Remote results of complex stage polymodal treatment of patients with locatory breast cancer
by: Yu. V. Dumanskyi, et al.
Published: (2020)

Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
by: Stepanenko, A.A., et al.
Published: (2012)

Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
by: A. A. Stepanenko, et al.
Published: (2012)

Mobile genetic elements and cancer. From mutations to gene therapy
by: Kozeretska, I.A., et al.
Published: (2011)

Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)

Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)

Analysis of mutations in GBA gene in Ukrainian patients with Gaucher disease
by: N. V. Olkhovych, et al.
Published: (2017)

Analysis of mutations in GBA gene in Ukrainian patients with Gaucher disease
by: Olkhovych, N.V., et al.
Published: (2017)

Hypermethylation of TUSC5 genes in breast cancer tissue
by: Bubnov, V., et al.
Published: (2012)

Клиническое значение рецепторов эстрогенов, прогестерона и онкобелка her-2/neu в клетках рака молочной железы
by: Петрухин, В.И., et al.
Published: (2002)

The ways to optimize the treatment of patients with regional breast cancer
by: V. H. Dubinina, et al.
Published: (2017)

Superroxide radicals: initiation of metastases in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2017)

Analysis CYP21A2 gene mutations technique in patients with congenital adrenal hyperplasia
by: Yu. Chernushyn, et al.
Published: (2014)

Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: L. A. Tashireva, et al.
Published: (2015)

Modern algorithm of treatment of patients with breast cancer and metastases in bone
by: O. V. Ponomareva, et al.
Published: (2015)

Experience of surgical treatment of patients with BRCA1/2-associated hereditary breast cancer
by: I. M. Motuziuk, et al.
Published: (2019)

Synergistic anti-cancer potential of Phenethyl isothiocyanate and Curcumin induces apoptosis and G2/M cell cycle arrest in HER2-positive breast cancer cells
by: S. Sirigiripeta, et al.
Published: (2023)

Individualization of neoadjuvant therapy in patients with locally-distributed breast cancer
by: Ju. Ju. Belevtsova
Published: (2019)

Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: L. E. Fishchuk, et al.
Published: (2013)

Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: Fishchuk, L.E., et al.
Published: (2013)

The frequency of BRCA1 mutation 5382INSC among women with breast cancer from three regions of Ukraine
by: Ye. V. Horodetska, et al.
Published: (2015)